Which statement about ranolazine (Ranexa), a fatty oxidase enzyme inhibitor, is true?
a. It causes coronary artery vasodilation.
b. It causes no gastrointestinal (GI) side effects.
c. It causes QT-interval prolongation.
d. It elevates LDL levels.
ANS: C
Baseline and follow-up ECGs should be obtained to evaluate the effects on the patient's QT incorrect interval. Increased coronary artery vasodilation is not an effect of this medication. This medication causes GI side effects such as abdominal pain. This medication does not elevate LDL levels.
You might also like to view...
A nephrostomy tube is inserted in a client with a large ureteral calculus. Which is the most important consideration in providing nursing care for this client?
A) Clamp the tube for no longer than 2 hours at a time. B) Maintain free, continuous urine drainage. C) Leave nephrostomy site open to the air. D) Use only sterile NSS to irrigate the tube.
A PHN is studying the rate of H1N1 in the community. If there are five cases of H1N1 in the community of 1,000 people, what is the prevalence rate? ____________________
Fill in the blank with correct word
The nurse is taking care of an 18-month-old child. When planning to take vital signs, the
nurse knows that when assessing the pulse, the most accurate pulse to assess is the: A) radial pulse. B) apical pulse (AP). C) pedal pulse. D) carotid pulse.
Which site is used for skin punctures in infants who are not walking?
a. The big toe b. The heel c. The thumb d. The earlobe